Tetralogic Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Tetralogic Pharmaceuticals's estimated annual revenue is currently $2M per year.
- Tetralogic Pharmaceuticals's estimated revenue per employee is $155,000
Employee Data
- Tetralogic Pharmaceuticals has 13 Employees.
- Tetralogic Pharmaceuticals grew their employee count by 8% last year.
Tetralogic Pharmaceuticals's People
Name | Title | Email/Phone |
---|
Tetralogic Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.4M | 9 | -10% | N/A | N/A |
#2 | $7.1M | 46 | 77% | N/A | N/A |
#3 | $14.4M | 93 | 27% | N/A | N/A |
#4 | $0.9M | 6 | 0% | N/A | N/A |
#5 | $1.6M | 10 | 43% | N/A | N/A |
#6 | $11.5M | 74 | 6% | N/A | N/A |
#7 | $0.9M | 11 | 22% | N/A | N/A |
#8 | $3.7M | 24 | -8% | N/A | N/A |
#9 | $2M | 13 | 18% | N/A | N/A |
#10 | $9.3M | 60 | 2% | N/A | N/A |
What Is Tetralogic Pharmaceuticals?
TetraLogic Pharmaceuticals (Nasdaq: TLOG) is a clinical-stage biopharmaceutical company focused on discovering, acquiring and developing novel product candidates to treat cancer and infectious diseases. We currently have two clinical-stage product candidates in development: birinapant and suberohydroxamic acid (4-methoxycarbonyl) phenyl ester (SHAPE).
keywords:N/AN/A
Total Funding
13
Number of Employees
$2M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.3M | 15 | -12% | N/A |
#2 | $2.3M | 15 | -29% | N/A |
#3 | $0.9M | 15 | -6% | $122M |
#4 | $2M | 16 | 14% | N/A |
#5 | $1.4M | 16 | 7% | N/A |